MCID: RCT005
MIFTS: 35

Rectum Neuroendocrine Neoplasm

Categories: Cancer diseases, Endocrine diseases, Gastrointestinal diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Rectum Neuroendocrine Neoplasm

MalaCards integrated aliases for Rectum Neuroendocrine Neoplasm:

Name: Rectum Neuroendocrine Neoplasm 12 15
Neuroendocrine Tumor of the Rectum 58
Neuroendocrine Tumor of Rectum 12
Rectal Neuroendocrine Neoplasm 71
Rectal Neuroendocrine Tumor 58
Net of the Rectum 58
Rectal Net 58

Classifications:

Orphanet: 58  
Rare gastroenterological diseases
Rare endocrine diseases


Summaries for Rectum Neuroendocrine Neoplasm

MalaCards based summary : Rectum Neuroendocrine Neoplasm, also known as neuroendocrine tumor of the rectum, is related to rectum adenocarcinoma and villous adenoma. An important gene associated with Rectum Neuroendocrine Neoplasm is VIP (Vasoactive Intestinal Peptide), and among its related pathways/superpathways is Gastric acid production. The drugs Hyaluronic acid and Pharmaceutical Solutions have been mentioned in the context of this disorder. Affiliated tissues include liver, lymph node and colon, and related phenotypes are weight loss and abdominal pain

Related Diseases for Rectum Neuroendocrine Neoplasm

Diseases related to Rectum Neuroendocrine Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 282, show less)
# Related Disease Score Top Affiliating Genes
1 rectum adenocarcinoma 30.1 KRT7 CDX2
2 villous adenoma 29.9 SST CDX2
3 carcinoid syndrome 29.7 SYP SST
4 constipation 29.2 VIP SST GAST
5 carcinoid tumors, intestinal 29.1 SYP SST GAST
6 neuroendocrine tumor 29.0 VIP SYP SST GAST CDX2
7 neuroendocrine carcinoma 28.9 SYP SST KRT7 GAST
8 adenoma 28.7 SYP SST KRT7 CDX2
9 anal canal paget's disease 10.2 KRT7 CDX2
10 anal paget's disease 10.2 KRT7 CDX2
11 anal gland adenocarcinoma 10.2 KRT7 CDX2
12 ureter adenocarcinoma 10.2 KRT7 CDX2
13 gastric signet ring cell adenocarcinoma 10.2 KRT7 CDX2
14 signet ring cell adenocarcinoma 10.2 KRT7 CDX2
15 pancreatic foamy gland adenocarcinoma 10.2 KRT7 CDX2
16 adenosquamous colon carcinoma 10.2 KRT7 CDX2
17 nasal cavity adenocarcinoma 10.2 KRT7 CDX2
18 anus adenocarcinoma 10.2 KRT7 CDX2
19 seminal vesicle adenocarcinoma 10.2 KRT7 CDX2
20 urinary bladder villous adenoma 10.2 KRT7 CDX2
21 bartholin's gland carcinoma 10.2 KRT7 CDX2
22 vulva adenocarcinoma 10.2 KRT7 CDX2
23 cystitis cystica 10.2 KRT7 CDX2
24 mucinous intrahepatic cholangiocarcinoma 10.2 KRT7 CDX2
25 ovarian seromucinous carcinoma 10.2 KRT7 CDX2
26 bartholin's gland disease 10.2 KRT7 CDX2
27 female urethral cancer 10.2 KRT7 CDX2
28 jejunal cancer 10.2 KRT7 CDX2
29 jejunal adenocarcinoma 10.2 KRT7 CDX2
30 ovarian cystadenoma 10.2 KRT7 GAST
31 anal canal adenocarcinoma 10.2 KRT7 CDX2
32 appendiceal neoplasm 10.2 KRT7 CDX2
33 peptic esophagitis 10.2 GAST CDX2
34 bile reflux 10.2 GAST CDX2
35 mucinous bronchioloalveolar adenocarcinoma 10.2 KRT7 CDX2
36 glandular cystitis 10.2 KRT7 CDX2
37 ovarian mucinous neoplasm 10.2 KRT7 CDX2
38 linitis plastica 10.2 KRT7 CDX2
39 thymus clear cell carcinoma 10.2 KRT7 CDX2
40 papillary adenocarcinoma 10.2 KRT7 CDX2
41 mucinous stomach adenocarcinoma 10.2 KRT7 CDX2
42 cervical adenoma malignum 10.2 KRT7 CDX2
43 appendix disease 10.2 KRT7 CDX2
44 duodenum adenocarcinoma 10.2 KRT7 CDX2
45 bladder clear cell adenocarcinoma 10.2 KRT7 CDX2
46 cervical neuroblastoma 10.2 VIP SYP
47 clear cell basal cell carcinoma 10.2 KRT7 CDX2
48 bladder adenocarcinoma 10.2 KRT7 CDX2
49 appendix cancer 10.1 KRT7 CDX2
50 esophageal adenosquamous carcinoma 10.1 KRT7 CDX2
51 ovarian mucinous adenocarcinoma 10.1 KRT7 CDX2
52 chronic cystitis 10.1 KRT7 CDX2
53 extracranial neuroblastoma 10.1 VIP SYP
54 intrahepatic bile duct adenoma 10.1 KRT7 AFP
55 nasal cavity cancer 10.1 KRT7 CDX2
56 rete testis neoplasm 10.1 KRT7 AFP
57 rete testis adenocarcinoma 10.1 KRT7 AFP
58 anal canal carcinoma 10.1 KRT7 CDX2
59 renal pelvis adenocarcinoma 10.1 KRT7 AFP
60 ovarian endodermal sinus tumor 10.1 KRT7 AFP
61 endodermal sinus tumor 10.1 KRT7 AFP
62 epididymal neoplasm 10.1 KRT7 AFP
63 bile duct cystadenocarcinoma 10.1 KRT7 AFP
64 endocervical carcinoma 10.1 KRT7 CDX2
65 intratubular embryonal carcinoma 10.1 KRT7 AFP
66 colonic lymphangioma 10.1 KRT7 AFP
67 middle ear adenocarcinoma 10.1 KRT7 AFP
68 liver sarcoma 10.1 KRT7 AFP
69 benign mesothelioma 10.1 KRT7 AFP
70 biliary tract benign neoplasm 10.1 KRT7 AFP
71 cystadenofibroma 10.1 KRT7 AFP
72 liver leiomyosarcoma 10.1 KRT7 AFP
73 mixed ductal-endocrine carcinoma 10.1 SYP GAST
74 sarcomatous intrahepatic cholangiocarcinoma 10.1 KRT7 AFP
75 middle ear carcinoma 10.1 KRT7 AFP
76 bile duct cysts 10.1 KRT7 AFP
77 pseudomyxoma peritonei 10.1 KRT7 CDX2
78 adenocarcinoma in situ 10.1 KRT7 CDX2
79 ampulla of vater adenocarcinoma 10.1 KRT7 CDX2
80 ovarian benign neoplasm 10.1 KRT7 AFP
81 leydig cell tumor 10.1 SYP AFP
82 adenomatoid tumor 10.0 KRT7 AFP
83 small cell carcinoma of the bladder 10.0 SYP KRT7
84 pineal region teratoma 10.0 SYP AFP
85 auditory system benign neoplasm 10.0 SYP KRT7
86 klatskin's tumor 10.0 KRT7 AFP
87 thymus sarcomatoid carcinoma 10.0 SYP AFP
88 adenocarcinoma 10.0
89 rare tumor 10.0
90 pancreatic serous cystadenocarcinoma 10.0 SYP KRT7
91 urinary bladder small cell neuroendocrine carcinoma 10.0 SYP KRT7
92 ureter small cell carcinoma 10.0 SYP KRT7
93 middle ear adenoma 10.0 SYP KRT7
94 papillary thymic adenocarcinoma 10.0 SYP AFP
95 jejunal neoplasm 10.0 SYP KRT7
96 gallbladder small cell carcinoma 10.0 SYP KRT7
97 sensory organ benign neoplasm 10.0 SYP KRT7
98 ovarian large-cell neuroendocrine carcinoma 10.0 SYP KRT7
99 ureteral benign neoplasm 10.0 SYP KRT7
100 papillary squamous carcinoma 10.0 SYP KRT7
101 pancreatic somatostatinoma 10.0 VIP SST
102 eccrine papillary adenocarcinoma 10.0 SYP KRT7
103 pancreatic acinar cell adenocarcinoma 10.0 SYP AFP
104 prostate neuroendocrine neoplasm 10.0 SYP KRT7
105 bladder lateral wall cancer 10.0 SYP KRT7
106 cerebrovascular benign neoplasm 10.0 SYP KRT7
107 endobronchial lipoma 10.0 SYP KRT7
108 granulosa cell tumor of the ovary 10.0 SYP KRT7
109 endocervical adenocarcinoma 10.0 KRT7 CDX2
110 uterus leiomyosarcoma 10.0 SYP KRT7
111 pineal gland cancer 10.0 SYP AFP
112 papillary adenoma 10.0 SYP KRT7
113 central epithelioid sarcoma 10.0 SYP KRT7
114 epithelioid sarcoma 10.0 SYP KRT7
115 vulvar proximal-type epithelioid sarcoma 10.0 SYP KRT7
116 chordoid glioma 10.0 SYP KRT7
117 cystic basal cell carcinoma 10.0 SYP KRT7
118 sex cord-gonadal stromal tumor 10.0 KRT7 AFP
119 ganglioneuroblastoma 10.0 VIP SYP
120 gastroesophageal reflux 10.0 VIP GAST CDX2
121 pulmonary sclerosing hemangioma 10.0 SYP KRT7
122 malignant teratoma 10.0 SYP AFP
123 retroperitoneum carcinoma 10.0 SYP KRT7
124 medulloepithelioma 10.0 SYP KRT7
125 colorectal adenoma 10.0
126 conn's syndrome 10.0
127 liver inflammatory pseudotumor 10.0
128 gastroenteropancreatic neuroendocrine neoplasm 10.0
129 bronchiolo-alveolar adenocarcinoma 10.0 KRT7 CDX2
130 obstructive hydrocephalus 10.0 SYP AFP
131 papilloma of choroid plexus 9.9 SYP KRT7
132 cecal disease 9.9 SYP KRT7
133 pineoblastoma 9.9 SYP AFP
134 basaloid squamous cell carcinoma 9.9 SYP KRT7
135 non-functioning pancreatic endocrine tumor 9.9 SST GAST
136 pleomorphic rhabdomyosarcoma 9.9 SYP KRT7
137 sweat gland cancer 9.9 SYP KRT7
138 duodenal gastrinoma 9.9 SST GAST
139 appendix lymphoma 9.9 SST GAST
140 respiratory system benign neoplasm 9.9 SYP KRT7
141 postgastrectomy syndrome 9.9 SST GAST
142 mesenchymal chondrosarcoma 9.9 SYP KRT7
143 gastric antral vascular ectasia 9.9 SST GAST
144 meckel diverticulum 9.9 SST CDX2
145 cryptosporidiosis 9.9 VIP SST
146 secretory diarrhea 9.9 VIP SST
147 reproductive organ benign neoplasm 9.9 KRT7 AFP
148 hypertriglyceridemia, familial 9.9
149 celiac disease 1 9.9
150 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
151 cervical cancer 9.9
152 colitis 9.9
153 scoliosis 9.9
154 anal fistula 9.9
155 rectum cancer 9.9
156 intestinal perforation 9.9
157 lipid metabolism disorder 9.9
158 peritonitis 9.9
159 ulcerative colitis 9.9
160 neurofibromatosis 9.9
161 crohn's disease 9.9
162 fatty liver disease 9.9
163 48,xyyy 9.9
164 acute sensory ataxic neuropathy 9.9
165 colon neuroendocrine neoplasm 9.9 VIP SYP CDX2
166 mucinous ovarian cystadenoma 9.9 KRT7 GAST CDX2
167 cardiovascular cancer 9.9 SYP KRT7
168 gastric diffuse adenocarcinoma 9.9 KRT7 GAST CDX2
169 gastrointestinal carcinoma 9.9 GAST CDX2
170 vascular cancer 9.9 SYP KRT7
171 duodenogastric reflux 9.9 SST GAST
172 microinvasive gastric cancer 9.9 GAST CDX2 AFP
173 small intestine cancer 9.9 KRT7 GAST CDX2
174 serotonin syndrome 9.9 SST GAST
175 large cell neuroendocrine carcinoma 9.9 SYP KRT7
176 dumping syndrome 9.8 SST GAST
177 hypertrophic pyloric stenosis 9.8 SST GAST
178 pyloric stenosis 9.8 SST GAST
179 zollinger-ellison syndrome 9.8 SST GAST
180 ovarian primitive germ cell tumor 9.8 KRT7 CDX2 AFP
181 pernicious anemia 9.8 SST GAST
182 epididymis adenocarcinoma 9.8 KRT7 CDX2 AFP
183 epididymis cancer 9.8 KRT7 CDX2 AFP
184 hepatoid adenocarcinoma 9.8 KRT7 CDX2 AFP
185 barrett esophagus 9.8 KRT7 GAST CDX2
186 anal neuroendocrine tumor 9.8 SYP SST
187 duodenal benign neoplasm 9.8 SYP SST
188 ampulla of vater neoplasm 9.8 SYP SST
189 intrahepatic cholangiocarcinoma 9.8 KRT7 CDX2 AFP
190 cholangiocarcinoma 9.8 KRT7 CDX2 AFP
191 esophageal varix 9.8 SST AFP
192 carotid body cancer 9.8 SYP SST
193 thyroid gland medullary carcinoma 9.8 SST GAST
194 gastric hemangioma 9.8 SYP SST
195 ectopic cushing syndrome 9.8 SYP SST
196 pulmonary neuroendocrine tumor 9.8 SYP SST
197 small intestine benign neoplasm 9.8 SYP SST
198 thymic carcinoma 9.8 SYP KRT7
199 ovary neuroendocrine neoplasm 9.8 SYP KRT7 CDX2
200 mucinous adenofibroma 9.8 SYP KRT7 CDX2
201 vaginal tubulovillous adenoma 9.8 SYP KRT7 CDX2
202 krukenberg carcinoma 9.8 SYP KRT7 CDX2
203 appendix adenocarcinoma 9.8 SYP KRT7 CDX2
204 vaginal adenoma 9.8 SYP KRT7 CDX2
205 nasal cavity olfactory neuroblastoma 9.8 SYP KRT7 CDX2
206 vaginal benign neoplasm 9.8 SYP KRT7 CDX2
207 horseshoe kidney 9.7 SYP KRT7 CDX2
208 peritoneal serous adenocarcinoma 9.7 SYP KRT7 CDX2
209 adrenal medulla cancer 9.7 SYP SST
210 spindle cell carcinoma 9.7 SYP KRT7
211 bile duct cancer 9.7 KRT7 CDX2 AFP
212 sclerosing hemangioma 9.7 SYP KRT7 GAST
213 glucagonoma 9.7 VIP SST GAST
214 pancreatic cholera 9.7 VIP SST GAST
215 endocrine pancreas disease 9.7 VIP SST GAST
216 functional gastric disease 9.7 VIP SST GAST
217 somatostatinoma 9.7 VIP SST GAST
218 gallbladder cancer 9.7 KRT7 CDX2 AFP
219 vipoma 9.7 VIP SST GAST
220 short bowel syndrome 9.7 VIP SST GAST
221 hyperinsulinemic hypoglycemia, familial, 2 9.7 SST GAST
222 hepatic vascular disease 9.7 SST AFP
223 cystadenoma 9.7 SYP KRT7 AFP
224 ovarian germ cell teratoma 9.7 SYP KRT7 AFP
225 mediastinal cancer 9.7 SYP KRT7 AFP
226 ovarian germ cell cancer 9.7 SYP KRT7 AFP
227 mature teratoma 9.7 SYP KRT7 AFP
228 subependymal giant cell astrocytoma 9.7 SYP SST
229 sertoli-leydig cell tumor 9.7 SYP KRT7 AFP
230 sertoli cell tumor 9.7 SYP KRT7 AFP
231 mixed cell type cancer 9.7 SYP KRT7 AFP
232 cavernous hemangioma 9.7 SYP KRT7 AFP
233 malignant pheochromocytoma 9.6 SYP SST
234 stomach disease 9.6 SST GAST CDX2
235 atrophic gastritis 9.6 SST GAST CDX2
236 gastritis 9.6 SST GAST CDX2
237 pulmonary blastoma 9.6 SYP SST
238 gastric ulcer 9.6 SST GAST
239 vein disease 9.6 SST AFP
240 mucinous adenocarcinoma 9.6 SST KRT7 CDX2
241 intestinal obstruction 9.6 SST KRT7 CDX2
242 binswanger's disease 9.6 VIP SYP SST
243 autonomic nervous system benign neoplasm 9.6 VIP SYP SST
244 peripheral nervous system benign neoplasm 9.6 VIP SYP SST
245 ganglioneuroma 9.6 VIP SYP SST
246 cystinosis 9.5 SST GAST
247 wilms tumor 1 9.5 SYP KRT7 AFP
248 gastrointestinal neuroendocrine benign tumor 9.5 SYP SST GAST
249 gastric neuroendocrine neoplasm 9.5 SYP SST GAST
250 pancreatic gastrinoma 9.5 SYP SST GAST
251 gastrointestinal neuroendocrine tumor 9.5 SYP SST GAST
252 gallbladder disease 9.5 SST KRT7 AFP
253 hydrocephalus 9.5 VIP SYP SST
254 endometrial small cell carcinoma 9.5 VIP SYP GAST AFP
255 dysgerminoma 9.5 KRT7 AFP
256 pancreatoblastoma 9.4 SYP SST AFP
257 merkel cell carcinoma 9.4 SYP SST KRT7
258 small cell carcinoma 9.4 SYP KRT7 GAST CDX2
259 cell type benign neoplasm 9.4 SYP SST KRT7
260 thymoma 9.4 SYP SST KRT7
261 cystic teratoma 9.4 SYP KRT7 CDX2 AFP
262 tubular adenocarcinoma 9.4 SYP KRT7 CDX2 AFP
263 benign teratoma 9.4 SYP KRT7 CDX2 AFP
264 gastrointestinal stromal tumor 9.3 SYP SST PIK3C2A
265 acinar cell carcinoma 9.3 SYP KRT7 GAST AFP
266 fibrolamellar carcinoma 9.3 SYP KRT7 GAST AFP
267 adrenal gland disease 9.3 SYP SST
268 duodenum cancer 9.3 SST KRT7 GAST CDX2
269 duodenum disease 9.3 SST KRT7 GAST CDX2
270 gastrointestinal system benign neoplasm 9.3 SST KRT7 GAST CDX2
271 pancreatic cystadenoma 9.2 VIP SYP SST GAST
272 gastrinoma 9.2 VIP SYP SST GAST
273 islet cell tumor 9.2 VIP SYP SST GAST
274 multiple endocrine neoplasia, type i 9.2 VIP SYP SST GAST
275 endocrine gland cancer 9.2 VIP SYP SST GAST
276 pheochromocytoma 9.1 VIP SYP SST KRT7
277 pancreatic endocrine carcinoma 9.1 SYP SST GAST AFP
278 thyroid gland cancer 9.1 SYP SST KRT7 GAST
279 small cell cancer of the lung 8.8 VIP SYP SST KRT7 GAST
280 teratoma 8.7 SYP SST KRT7 CDX2 AFP
281 pancreatic cancer 8.7 VIP SST KRT7 GAST CDX2
282 gastric adenocarcinoma 8.6 VIP SST KRT7 GAST CDX2 AFP

Graphical network of the top 20 diseases related to Rectum Neuroendocrine Neoplasm:



Diseases related to Rectum Neuroendocrine Neoplasm

Symptoms & Phenotypes for Rectum Neuroendocrine Neoplasm

Human phenotypes related to Rectum Neuroendocrine Neoplasm:

58 31 (showing 25, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 weight loss 58 31 frequent (33%) Frequent (79-30%) HP:0001824
2 abdominal pain 58 31 frequent (33%) Frequent (79-30%) HP:0002027
3 anorexia 58 31 frequent (33%) Frequent (79-30%) HP:0002039
4 constipation 58 31 frequent (33%) Frequent (79-30%) HP:0002019
5 hematochezia 58 31 frequent (33%) Frequent (79-30%) HP:0002573
6 tenesmus 58 31 frequent (33%) Frequent (79-30%) HP:0012702
7 hypoactive bowel sounds 58 31 frequent (33%) Frequent (79-30%) HP:0030144
8 atypical pulmonary carcinoid tumor 58 31 frequent (33%) Frequent (79-30%) HP:0030446
9 hepatomegaly 58 31 occasional (7.5%) Occasional (29-5%) HP:0002240
10 elevated hepatic transaminase 58 31 occasional (7.5%) Occasional (29-5%) HP:0002910
11 chronic noninfectious lymphadenopathy 58 31 occasional (7.5%) Occasional (29-5%) HP:0002730
12 melena 58 31 occasional (7.5%) Occasional (29-5%) HP:0002249
13 hypotension 58 31 very rare (1%) Very rare (<4-1%) HP:0002615
14 tricuspid regurgitation 58 31 very rare (1%) Very rare (<4-1%) HP:0005180
15 facial telangiectasia 58 31 very rare (1%) Very rare (<4-1%) HP:0007380
16 palpitations 58 31 very rare (1%) Very rare (<4-1%) HP:0001962
17 right ventricular failure 58 31 very rare (1%) Very rare (<4-1%) HP:0001708
18 lack of bowel sounds 58 31 very rare (1%) Very rare (<4-1%) HP:0030145
19 increased serum serotonin 58 31 very rare (1%) Very rare (<4-1%) HP:0003144
20 bronchospasm 58 31 very rare (1%) Very rare (<4-1%) HP:0025428
21 protracted diarrhea 58 31 very rare (1%) Very rare (<4-1%) HP:0004385
22 bowel urgency 58 31 very rare (1%) Very rare (<4-1%) HP:0012701
23 abnormal pulmonary valve cusp morphology 58 31 very rare (1%) Very rare (<4-1%) HP:0031566
24 carcinoid tumor 58 Obligate (100%)
25 bloody diarrhea 58 Frequent (79-30%)

MGI Mouse Phenotypes related to Rectum Neuroendocrine Neoplasm:

45 (showing 1, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.17 AFP CDX2 GAST KRT7 PIK3C2A SST

Drugs & Therapeutics for Rectum Neuroendocrine Neoplasm

Drugs for Rectum Neuroendocrine Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 2, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hyaluronic acid Approved, Vet_approved 9004-61-9 53477741
2 Pharmaceutical Solutions

Interventional clinical trials:

(showing 1, show less)
# Name Status NCT ID Phase Drugs
1 Cap Endoscopic Mucosal Resection(EMR-C) Versus Endoscopic Submucosal Dissection(ESD) for Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm Not yet recruiting NCT03982264

Search NIH Clinical Center for Rectum Neuroendocrine Neoplasm

Genetic Tests for Rectum Neuroendocrine Neoplasm

Anatomical Context for Rectum Neuroendocrine Neoplasm

MalaCards organs/tissues related to Rectum Neuroendocrine Neoplasm:

40
Liver, Lymph Node, Colon, Prostate

Publications for Rectum Neuroendocrine Neoplasm

Articles related to Rectum Neuroendocrine Neoplasm:

(showing 69, show less)
# Title Authors PMID Year
1
A rectal neuroendocrine tumor in a patient with Crohn's disease: a case report and literature review. 61
31705376 2020
2
Underwater endoscopic mucosal resection for esophageal granular cell tumor sized more than 1 cm. 61
32512623 2020
3
Cut the weeds and dig up the roots: clip-and-snare assisted endoscopic mucosal resection of a rectal neuroendocrine tumor. 61
32483787 2020
4
Successful further endoscopic mucosal resection with an over-the-scope clip with circumferential mucosal incision for a residual rectal neuroendocrine tumor. 61
31909845 2020
5
Rectal neuroendocrine tumor - Case report. 61
31635854 2020
6
Rectal neuroendocrine tumor developing lateral lymph node metastasis after curative resection: a case report. 61
32284069 2020
7
[Case of a 5mm Rectal Neuroendocrine Tumor(G1)with Lymph Node Metastasis]. 61
32389973 2020
8
Single Rectal Neuroendocrine Tumor Associated with Multiple Endocrine Cell Micronests. 61
31666465 2020
9
Synchronous NET and colorectal cancer development: a case report. 61
31919616 2020
10
Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis. 61
31585816 2019
11
Rectal neuroendocrine tumor presenting as a polyp with hepatic metastases. 61
31375265 2019
12
Endoscopic Resection of a Rectal Neuroendocrine Tumor: Hybrid Endoscopic Submucosal Dissection. 61
30976620 2019
13
Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. 61
30366604 2019
14
Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors. 61
30894571 2019
15
Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors. 61
30742649 2019
16
Stereotactic Pelvic Navigation With Augmented Reality for Transanal Total Mesorectal Excision. 61
30531268 2019
17
Intratumoral Hemorrhage of Liver Metastasis from a Rectal Neuroendocrine Tumor. 61
30210114 2019
18
[Transanal Minimally Invasive Surgery for Rectal Neuroendocrine Tumor]. 61
30692455 2018
19
[A Small Rectal Neuroendocrine Tumor of Less Than 5mm with Lymph Node Metastasis]. 61
30692419 2018
20
Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors. 61
30167779 2018
21
A case report of neuroendocrine tumor (G3) at lower rectum with liver metastasis. 61
30235718 2018
22
[Endoscopic Treatment Outcome of Rectal Neuroendocrine Tumors Removed by Ligation-assisted Endoscopic Submucosal Resection]. 61
30270594 2018
23
Rectal Carcinoid Tumor With Liver Metastases Treated by Local Excision and Orthotopic Liver Transplant With Long-term Follow-up. 61
28350289 2018
24
Acute Pancreatitis Following Peptide Receptor Radionuclide Therapy: An Unusual Adverse Event. 61
29762236 2018
25
Rectal Neuroendocrine Tumor with Synchronous Pancreatic Metastasis: A Case Report. 61
29961930 2018
26
Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor. 61
29866049 2018
27
A small, well-differentiated rectal neuroendocrine tumor with multiple lymph node metastases: A case report. 61
29725436 2018
28
Rectal neuroendocrine tumor as an incidental finding in the doughnut of rectal adenocarcinoma resection specimen. What would have happened if we had not examined the doughnut? 61
29169613 2018
29
Tumor Cystic Necrosis Following Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors. 61
29356741 2018
30
A 10-year History of a Diminutive Rectal Neuroendocrine Tumor. 61
29151521 2018
31
Expanding the Spectrum of Colonic Manifestations in Tuberous Sclerosis: L-Cell Neuroendocrine Tumor Arising in the Background of Rectal PEComa. 61
28733877 2018
32
Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter. 61
29344571 2018
33
Local resection of rectal neuroendocrine tumor with first clinical manifestation of giant liver metastasis by transanal endoscopic microsurgery: A case report. 61
29390320 2017
34
A rare association of celiac disease and rectal neuroendocrine tumor. 61
28755101 2017
35
Evaluation of treatment for rectal neuroendocrine tumors sized under 20 mm in comparison with the WHO 2010 guidelines. 61
28894583 2017
36
[Standardized development of transanal endoscopic microsurgery]. 61
28836241 2017
37
Rectal neuroendocrine tumor with an exceptional behaviour. 61
27129890 2017
38
Endoscopic Submucosal Dissection of a Rectal Neuroendocrine Tumor Using Linked Color Imaging Technique. 61
28469111 2017
39
Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors? 61
28373770 2017
40
Recurrence 30 Years after Surgical Resection of a Localized Rectal Neuroendocrine Tumor. 61
28626177 2017
41
Rectal Neuroendocrine Tumor G1 with a Solitary Hepatic Metastatic Lesion. 61
28154272 2017
42
Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center. 61
27025841 2016
43
Enhanced detection of lymphovascular invasion in small rectal neuroendocrine tumors using D2-40 and Elastica van Gieson immunohistochemical analysis. 61
27748061 2016
44
[A Rare Complication of Transcatheter Arterial Injection for Multiple Liver Metastases of Rectal Neuroendocrine Tumor - A Case Report]. 61
28133133 2016
45
[Multiple Metachronal Liver Metastases from a Rectal Neuroendocrine Tumor Controlled by Repeated Transcatheter Arterial Chemoembolization]. 61
28133140 2016
46
Two Cases of Rectal Neuroendocrine Tumor Resection Combined with Dissection of the Circular Muscle Layer Using the Endoscopic Submucosal Dissection Technique. 61
27990103 2016
47
A case of rectal carcinoid, 7 mm in diameter, with skip metastasis to the lateral lymph node. 61
27073660 2016
48
Central calcification in a rectal neuroendocrine tumor. 61
26620884 2016
49
Rectal neuroendocrine tumor with uncommon metastatic spread: A case report and review of literature. 61
26909138 2016
50
"Underwater" endoscopic submucosal dissection: a novel technique for complete resection of a rectal neuroendocrine tumor. 61
26890547 2016
51
Interventional therapy for rectal neuroendocrine tumor with liver metastases: report of one case. 61
28138640 2016
52
Metastatic rectal neuroendocrine tumor presenting as an inguinal mass: A case report and review of literature. 61
27442427 2016
53
New technique for treating abdominal surgical site infection using CT woundgraphy and NPWT: A case report. 61
27002290 2016
54
Endoscopic Resection for Small Rectal Neuroendocrine Tumors: Comparison of Endoscopic Submucosal Resection with Band Ligation and Endoscopic Submucosal Dissection. 61
27525004 2016
55
[Long-Term Survival with Multidisciplinary Therapy for Rectal NET with Liver Metastases--A Case Report]. 61
26805201 2015
56
PET/CT and Bremsstrahlung Imaging After 90Y DOTANOC Therapy for Rectal Net With Liver Metastases. 61
26204211 2015
57
Finding a Needle in a Haystack: The Diagnosis of a Rectal Neuroendocrine Tumor by Transrectal Prostate Biopsy. 61
28868411 2015
58
Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors. 61
26309365 2015
59
Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors. 61
26290641 2015
60
Laparoscopic surgery after endoscopic resection for rectal cancer and neuroendocrine tumors. 61
25277475 2015
61
Natural course of an untreated metastatic perirectal lymph node after the endoscopic resection of a rectal neuroendocrine tumor. 61
25932004 2015
62
Over-the-scope clip-assisted endoscopic full-thickness resection after incomplete resection of a rectal neuroendocrine tumor. 61
25643136 2015
63
A case of rectal neuroendocrine tumor presenting as polyp. 61
25625492 2015
64
Endoscopic full-thickness resection for suspected residual rectal neuroendocrine tumor and closure of the defect with a new suturing system. 61
26610082 2015
65
A tailored approach for endoscopic treatment of small rectal neuroendocrine tumor. 61
24853847 2014
66
Rectal neuroendocrine tumor. 61
25040208 2014
67
[Risk factors associated with lymph node metastasis and prognosis in 69 patients with rectal neuroendocrine tumors]. 61
24953366 2014
68
Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution. 61
22647741 2012
69
Rectal neuroendocrine tumor in ulcerative colitis. 61
21618361 2011

Variations for Rectum Neuroendocrine Neoplasm

Expression for Rectum Neuroendocrine Neoplasm

Search GEO for disease gene expression data for Rectum Neuroendocrine Neoplasm.

Pathways for Rectum Neuroendocrine Neoplasm

Pathways related to Rectum Neuroendocrine Neoplasm according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1 9.47 VIP GAST

GO Terms for Rectum Neuroendocrine Neoplasm

Molecular functions related to Rectum Neuroendocrine Neoplasm according to GeneCards Suite gene sharing:

(showing 1, show less)
# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.8 VIP SST GAST

Sources for Rectum Neuroendocrine Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....